At the completion of this activity, the participant will be able to:
1. Distinguish pharmacokinetic and pharmacodynamic properties of available hyperosmolar therapies
2. Describe dosing strategies and monitoring parameters of hyperosmolar therapy administration
3. Translate available literature supporting hyperosmolar therapy options to specific causes of cerebral edema
4. Review hyperosmolar therapy safety and infusion considerations
Session date:
10/26/2020 - 12:00pm to 1:00pm EDT
Location:
Zoom: https://zoom.us/j/95024204563
Dial: 669 900 6833 or 253 215 8782
Meeting ID: 950 2420 4563
Passcode: 681823
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance